Comment on Ryan, et al. Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non ‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D). Diabetes Obes Metab. 2018; doi: 10.1111/dom.13424.

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Patrick B. Ryan , Norm Rosenthal Source Type: research